Extending landscape of volatile metabolites as novel diagnostic biomarkers of inflammatory bowel disease – a review
- 6 November 2015
- journal article
- review article
- Published by Informa UK Limited in Scandinavian Journal of Gastroenterology
- Vol. 51 (4), 385-392
- https://doi.org/10.3109/00365521.2015.1105286
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- A Meta-Analysis of the Utility of C-Reactive Protein, Erythrocyte Sedimentation Rate, Fecal Calprotectin, and Fecal Lactoferrin to Exclude Inflammatory Bowel Disease in Adults With IBSAmerican Journal Of Gastroenterology, 2015
- Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysisBMJ, 2010
- Diagnostic Precision of Fecal Calprotectin for Inflammatory Bowel Disease and Colorectal MalignancyThe American Journal of Gastroenterology, 2007
- Laboratory markers in IBD: useful, magic, or unnecessary toys?Gut, 2006
- C-Reactive Protein as a Marker for Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2004
- Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosisGastroenterology, 2004
- Faecal calprotectin: a marker of inflammation throughout the intestinal tractEuropean Journal of Gastroenterology & Hepatology, 2002
- Non-invasive investigation of inflammatory bowel diseaseWorld Journal of Gastroenterology, 2001
- Assessment of Disease Activity in Ulcerative Colitis by Faecal Calprotectin, a Novel Granulocyte Marker ProteinDigestion, 1997
- The Clinical Significance of Serum C Reactive Protein Levels in Crohnʼs DiseaseJournal of Clinical Gastroenterology, 1988